Greenwich LifeSciences, Inc. (GLSI)
- Previous Close
12.62 - Open
12.43 - Bid --
- Ask --
- Day's Range
12.05 - 12.90 - 52 Week Range
7.58 - 21.44 - Volume
30,884 - Avg. Volume
52,595 - Market Cap (intraday)
158.919M - Beta (5Y Monthly) 3.19
- PE Ratio (TTM)
-- - EPS (TTM)
-0.69 - Earnings Date May 22, 2024 - May 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
36.00
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
greenwichlifesciences.comRecent News: GLSI
Performance Overview: GLSI
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GLSI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GLSI
Valuation Measures
Market Cap
158.92M
Enterprise Value
151.93M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
23.72
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-16.29
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-56.96%
Return on Equity (ttm)
-89.30%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-8.89M
Diluted EPS (ttm)
-0.69
Balance Sheet and Cash Flow
Total Cash (mrq)
6.99M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.42M
Research Analysis: GLSI
Company Insights: GLSI
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: GLSI
Daily – Vickers Top Buyers & Sellers for 04/04/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 03/27/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 03/25/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 02/22/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.